Literature DB >> 30605147

Illumina swallows PacBio in long shot for market domination.

Michael Eisenstein.   

Abstract

Year:  2019        PMID: 30605147     DOI: 10.1038/nbt0119-3

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Oxford Nanopore announcement sets sequencing sector abuzz.

Authors:  Michael Eisenstein
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

2.  Roche breaks with PacBio, opts for Genia.

Authors: 
Journal:  Nat Biotechnol       Date:  2017-02-08       Impact factor: 54.908

3.  The battle for sequencing supremacy.

Authors:  Michael Eisenstein
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

4.  Companies 'going long' generate sequencing buzz at Marco Island.

Authors:  Michael Eisenstein
Journal:  Nat Biotechnol       Date:  2013-04       Impact factor: 54.908

5.  Illumina sues Oxford Nanopore.

Authors: 
Journal:  Nat Biotechnol       Date:  2016-04       Impact factor: 54.908

6.  The long view on sequencing.

Authors: 
Journal:  Nat Biotechnol       Date:  2018-04-05       Impact factor: 54.908

  6 in total
  1 in total

Review 1.  The current landscape of single-cell transcriptomics for cancer immunotherapy.

Authors:  Puneeth Guruprasad; Yong Gu Lee; Ki Hyun Kim; Marco Ruella
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 17.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.